CD4 and cholangiocarcinoma: These findings have been validated in humans, where the adoptive transfer of large numbers of CD4+ T cells expanded from a tumor-specific CD4+ T-cell population resulted in complete response in patients with melanoma and cholangiocarcinoma (12, 13).